3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Metastatic Adenocarcinoma of the Pancreas
1
Interventions
pembrolizumab
11
Fluorouracil
10
Oxaliplatin
8
Nivolumab
7
Leucovorin
6
Cisplatin
6
Capecitabine
6
Sorafenib
5
Ipilimumab
5
Cetuximab
5
Bevacizumab
5
Irinotecan
4
trifluridine tipiracil drug combination
3
trastuzumab deruxtecan
3
durvalumab
3
cabozantinib
3
Trastuzumab
3
Paclitaxel
3
zolbetuximab
2
trametinib
2
sodium thiosulfate
2
selpercatinib
2
relatlimab
2
lenvatinib
2
larotrectinib
2
encorafenib
2
dabrafenib
2
binimetinib
2
X-Rays
2
Specimen Handling
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has announcements
×
irinotecan sucrosofate
×
Gastrointestinal
×
Clear all
NCT04083235
2026-04-20
NAPOLI 3
Ipsen
Phase 3
Completed
770 enrolled
13 charts
1 FDA